SCHEMBL20708423

SCHEMBL20708423

Cc1cncc(N2CCN(C(=O)CCC3(C4CC4)NC(=O)NC3=O)CC2)c1

nearest known ligand 0.76

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ ADAMTS5 Q9UNA0 17/20 0.76
▸ MMP2 P08253 7/20 0.76
▸ ADAM17 P78536 3/20 0.69
▸ ADAMTS4 O75173 4/20 0.65
▸ MMP13 P45452 3/20 0.65
▸ ADAMTS1 Q9UHI8 1/20 0.65
▸ MMP1 P03956 1/20 0.61
▸ MMP12 P39900 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20708268 0.89 ADAMTS5 (0.80) ADAMTS5MMP2ADAM17ADAMTS4MMP13
SCHEMBL20708294 0.89 ADAMTS5 (0.75) ADAMTS5MMP2ADAM17ADAMTS4MMP13
SCHEMBL22892283 0.88 ADAMTS4 (0.77) ADAMTS5MMP2ADAM17ADAMTS4MMP13
SCHEMBL20708321 0.87 MMP2 (0.77) ADAMTS5MMP2ADAM17ADAMTS4MMP13
SCHEMBL17871466 0.86 ADAMTS5 (1.00) ADAMTS5MMP2ADAM17ADAMTS4
SCHEMBL20708307 0.86 ADAMTS5 (0.76) ADAMTS5MMP2ADAM17ADAMTS4MMP13
SCHEMBL20708300 0.83 MMP2 (0.78) ADAMTS5MMP2ADAM17ADAMTS4MMP13
SCHEMBL20708614 0.83 ADAMTS5 (0.77) ADAMTS5MMP2ADAM17ADAMTS4MMP13
SCHEMBL17871419 0.83 MMP2 (1.00) ADAMTS5MMP2ADAM17ADAMTS4MMP13
SCHEMBL20708613 0.82 ADAMTS5 (0.75) ADAMTS5MMP2ADAM17ADAMTS4MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3575294-A1 5-[(PIPERAZIN-1-YL)-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AS ADAMTS INHIBITORS FOR THE TREATMENT OF OSTEOARTHRITIS Les Laboratoires Servier (FR) 2019-12-04 — — EP disclosed
EP-3237406-B1 5-[(PIPERAZIN-1-YL)-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AS ADAMTS INHIBITORS FOR THE TREATMENT OF OSTEOARTHRITIS GALAPAGOS NV (BE) 2019-02-06 — — EP disclosed
Send feedback